Vaccinex, Inc. (VCNX) Free cash flow 2017–2024
Vaccinex, Inc. (VCNX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$16.2MFY2024 · since FY2017: -$21.5M → -$16.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$16.2M | +24.4% |
| FY2023 | -$21.4M | -11.9% |
| FY2022 | -$19.2M | +24.3% |
| FY2021 | -$25.3M | +12.5% |
| FY2020 | -$28.9M | +6.0% |
| FY2019 | -$30.8M | -20.7% |
| FY2018 | -$25.5M | -18.9% |
| FY2017 | -$21.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice